“…Overexpression of USP22 is associated with increased tumor growth, metastasis, and risk of death from cancer [8] . Recently, ATXN7L3, ENY2, and USP22 were found to be capable of leaving SAGA to meet substrates at a distance [9] . While away from SAGA, ENY2 and ATXN7L3 can swap USP22 for either of deubiquitinases USP27x or USP51 [10] .…”